Zhengping Hu

580 total citations
29 papers, 424 citations indexed

About

Zhengping Hu is a scholar working on Molecular Biology, Oncology and Ophthalmology. According to data from OpenAlex, Zhengping Hu has authored 29 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Ophthalmology. Recurrent topics in Zhengping Hu's work include Angiogenesis and VEGF in Cancer (6 papers), CAR-T cell therapy research (3 papers) and Connexins and lens biology (3 papers). Zhengping Hu is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), CAR-T cell therapy research (3 papers) and Connexins and lens biology (3 papers). Zhengping Hu collaborates with scholars based in China, United States and Switzerland. Zhengping Hu's co-authors include Patrìcia A. D'Amore, Jingwei Tian, Liang Ye, Fenghua Fu, Hongbo Wang, Sumin Gu, Manuel A. Riquelme, Jean X. Jiang, Guangying Du and Yin‐Shan Ng and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Circulation Research.

In The Last Decade

Zhengping Hu

26 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhengping Hu China 15 206 88 63 51 45 29 424
Miryam A. Fragoso United States 10 194 0.9× 73 0.8× 103 1.6× 69 1.4× 28 0.6× 13 571
Xiaochan Dai China 8 253 1.2× 26 0.3× 34 0.5× 84 1.6× 33 0.7× 15 463
Sneha Sundaram United States 16 313 1.5× 173 2.0× 40 0.6× 15 0.3× 55 1.2× 37 698
Yu Qin Netherlands 12 213 1.0× 21 0.2× 23 0.4× 28 0.5× 17 0.4× 14 373
En‐Chi Liao Taiwan 12 159 0.8× 35 0.4× 29 0.5× 40 0.8× 29 0.6× 24 383
Qiang Ye China 9 86 0.4× 33 0.4× 66 1.0× 14 0.3× 8 0.2× 15 411
Xueyan Yao China 9 158 0.8× 20 0.2× 26 0.4× 59 1.2× 13 0.3× 23 358
Zhao Liu China 11 169 0.8× 35 0.4× 23 0.4× 20 0.4× 14 0.3× 30 452

Countries citing papers authored by Zhengping Hu

Since Specialization
Citations

This map shows the geographic impact of Zhengping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengping Hu more than expected).

Fields of papers citing papers by Zhengping Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengping Hu. The network helps show where Zhengping Hu may publish in the future.

Co-authorship network of co-authors of Zhengping Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengping Hu. A scholar is included among the top collaborators of Zhengping Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengping Hu. Zhengping Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skowronska‐Krawczyk, Dorota, Silvia C. Finnemann, Maria B. Grant, et al.. (2025). Features that distinguish age-related macular degeneration from aging. Experimental Eye Research. 254. 110303–110303. 1 indexed citations
3.
Hu, Zhengping, Fengyang Lei, Ramon Bossardi Ramos, et al.. (2024). Loss of the Endothelial Glycocalyx Component EMCN Leads to Glomerular Impairment. Circulation Research. 136(1). 59–74. 4 indexed citations
4.
Chaudhary, Suman, et al.. (2024). Endomucin selectively regulates vascular endothelial growth factor receptor-2 endocytosis through its interaction with AP2. Cell Communication and Signaling. 22(1). 225–225. 3 indexed citations
5.
Chaudhary, Suman, et al.. (2024). Endomucin regulates the endothelial cytoskeleton independently of VEGF. Experimental Eye Research. 250. 110150–110150. 2 indexed citations
6.
Ye, Liang, Chunmei Li, Wanglin Jiang, et al.. (2023). Subacute toxicity evaluations of LPM3480392 in rats, a full µ-opioid receptor biased agonist. Frontiers in Pharmacology. 14. 1218380–1218380. 2 indexed citations
7.
Ye, Liang, Yifei Yang, Chunmei Li, et al.. (2023). Synthesis and evaluation of piperazinotriazoles. Discovery of a potent and orally bioavailable neurokinin-3 receptor inhibitor. European Journal of Medicinal Chemistry. 257. 115486–115486.
8.
Hu, Zhengping, Dina B. AbuSamra, Magali Saint‐Geniez, et al.. (2021). Galectin-3 Enhances Vascular Endothelial Growth Factor-A Receptor 2 Activity in the Presence of Vascular Endothelial Growth Factor. Frontiers in Cell and Developmental Biology. 9. 734346–734346. 7 indexed citations
10.
Hu, Zhengping, Kahira L. Saez‐Torres, Magali Saint‐Geniez, et al.. (2020). Elements of the Endomucin Extracellular Domain Essential for VEGF-Induced VEGFR2 Activity. Cells. 9(6). 1413–1413. 15 indexed citations
11.
Hu, Zhengping, Guangying Du, Pengfei Yu, et al.. (2020). PCC0208023, a potent SHP2 allosteric inhibitor, imparts an antitumor effect against KRAS mutant colorectal cancer. Toxicology and Applied Pharmacology. 398. 115019–115019. 17 indexed citations
12.
Hu, Zhengping, Pengfei Yu, Guangying Du, et al.. (2020). PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice. PLoS ONE. 15(3). e0228339–e0228339. 27 indexed citations
13.
Chen, Na, Zhengping Hu, Yanhui Yang, Haote Han, & Hetian Lei. (2019). Inactive Cas9 blocks vitreous-induced expression of Mdm2 and proliferation and survival of retinal pigment epithelial cells. Experimental Eye Research. 186. 107716–107716. 11 indexed citations
14.
Zhao, Han, Wanpeng Wang, Zhengping Hu, & Baihua Chen. (2019). Long-term outcome of scleral-fixated intraocular lens implantation without conjunctival peritomies and sclerotomy in ocular trauma patients. BMC Ophthalmology. 19(1). 164–164. 13 indexed citations
15.
Hu, Zhengping, Manuel A. Riquelme, Bin Wang, et al.. (2018). Cataract-associated connexin 46 mutation alters its interaction with calmodulin and function of hemichannels. Journal of Biological Chemistry. 293(7). 2573–2585. 16 indexed citations
16.
Hu, Zhengping, Liang Ye, Yingying Xing, Jinhang Hu, & Tao Xi. (2018). Combined SEP and anti-PD-L1 antibody produces a synergistic antitumor effect in B16-F10 melanoma-bearing mice. Scientific Reports. 8(1). 217–217. 20 indexed citations
17.
Ma, Gaoen, Wenyi Wu, Zhengping Hu, et al.. (2017). Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy. Investigative Ophthalmology & Visual Science. 58(12). 5361–5361. 16 indexed citations
18.
Zhang, Dan, Jia Mi, Xianbing Liu, et al.. (2016). Label-free proteomic analysis of placental proteins during Toxoplasma gondii infection. Journal of Proteomics. 150. 31–39. 10 indexed citations
19.
Ye, Liang, Zhengping Hu, Guangying Du, et al.. (2012). Antidepressant-like effects of the extract from Cimicifuga foetida L.. Journal of Ethnopharmacology. 144(3). 683–691. 31 indexed citations
20.
Ye, Liang, et al.. (2012). Antitumor effect and toxicity of Lipusu in rat ovarian cancer xenografts. Food and Chemical Toxicology. 52. 200–206. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026